CMA highlights competition concerns between Imprivata and Isosec

The Competition and Markets Authority (CMA) has decided not to refer the merger between healthcare solution providers, Imprivata and Isosec and has confirmed the deal has been abandoned. The CMA found evidence during its initial ‘Phase 1’ investigation, which suggested that Imprivata and Isosec are important rivals in the healthcare management solutions sector. Ultimately, the […]

CMA highlights competition concerns between Imprivata and Isosec Read More »